Title of article
Stem cell transplantation for non-malignant disorders
Author/Authors
Colin G. Steward، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2000
Pages
21
From page
343
To page
363
Abstract
Stem cell transplantation (SCT) can be used to cure or ameliorate a wide variety of non-malignant diseases. These range from inherent defects of haemopoietic cell production or function, through metabolic diseases (where blood cells are providing in vivo enzyme therapy to solid organs), to severe autoimmune diseases. However, although transplantation has revolutionized the treatment of many of the diseases discussed, severe toxicities remain. In some cases these are inherent to the disease concerned but frequently they relate to the conditioning regime or post-transplant complications such as graft-versus-host disease (GvHD). This chapter concentrates on the indications for transplant, outcome statistics and problems inherent in particular conditions, seen in the light of technological improvements during the 1990s and the potential impact of enzyme and gene therapies.
Keywords
Bone marrow transplantation , adrenoleukodystrophy (ALD) , congenital erythro-poietic porphyria (CEP) , globoid cell leukodystrophy (GLD) , haematopoietic stem celltransplantation , haemoglobinopathies , haemophagocytic lymphohistiocytosis (HLH) , malignantinfantile osteopetrosis (MIOP) , metachromatic leukodystrophy (MLD) , mucopolysaccharidoses(MPS).
Journal title
Best Practice and Research Clinical Haematology
Serial Year
2000
Journal title
Best Practice and Research Clinical Haematology
Record number
467388
Link To Document